A J Tyack|J D Ellis - JoVE Visualize

Showing results (31-40 of 41) with videos related to

Pageof 5

Sort By:

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995

Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and humanT Prueksaritanont, S K Balani, L M Dwyer, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2005

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based studyL A Donnelly, A D Morris, B M Frier, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001

PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolitesB K Wong, D DeFeo-Jones, R E Jones, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|July 20, 2005

Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmologyG P Leese, A D Morris, K Swaminathan, et al.

Pharmaceutical Research|March 1, 1994

Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dogJ S Barrett, R J Gould, J D Ellis, et al.

Genetics and Molecular Research : GMR|January 7, 2014

Protein levels and colony development of Africanized and European honey bees fed natural and artificial dietsM M Morais, A P Turcatto, R A Pereira, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999

Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999

In vitro and in vivo studies on the metabolism of tirofibanS Vickers, A D Theoharides, B Arison, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1996

Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studiesT Prueksaritanont, L M Gorham, J D Ellis, et al.

Journal of Medicinal Chemistry|July 14, 2000

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasiaJ C Barrow, P G Nantermet, H G Selnick, et al.

Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:

Pageof 5

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995

Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and humanT Prueksaritanont, S K Balani, L M Dwyer, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2005

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based studyL A Donnelly, A D Morris, B M Frier, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001

PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolitesB K Wong, D DeFeo-Jones, R E Jones, et al.

Diabetic Medicine : a Journal of the British Diabetic Association|July 20, 2005

Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmologyG P Leese, A D Morris, K Swaminathan, et al.

Pharmaceutical Research|March 1, 1994

Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dogJ S Barrett, R J Gould, J D Ellis, et al.

Genetics and Molecular Research : GMR|January 7, 2014

Protein levels and colony development of Africanized and European honey bees fed natural and artificial dietsM M Morais, A P Turcatto, R A Pereira, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 1999

Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humansK P Vyas, R A Halpin, L A Geer, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999

In vitro and in vivo studies on the metabolism of tirofibanS Vickers, A D Theoharides, B Arison, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1996

Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studiesT Prueksaritanont, L M Gorham, J D Ellis, et al.

Journal of Medicinal Chemistry|July 14, 2000

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasiaJ C Barrow, P G Nantermet, H G Selnick, et al.

Pageof 5